このページは自動翻訳されたものであり、翻訳の正確性は保証されていません。を参照してください。 英語版 ソーステキスト用。

一緒に対処する: がんに対するカップルベースの介入 (CCST2)

2026年11月13日 更新者:Duke University

進行がんのためのカップルコミュニケーションスキルトレーニング

The objective of the proposed study is to evaluate the Couple Communication Skills Training (CCST) intervention in 250 patients with advanced cancer and their spouses/intimate partners. Couples will be randomized 1:1 to receive either the CCST or to an attention control condition (Healthy Living Information; HLI). We will evaluate CCST effects on a range of patient and partner relationship and psychological outcomes.

調査の概要

詳細な説明

For patients and their intimate partners, advanced cancer poses significant challenges that can negatively impact both individuals and the couple's collective well-being. Couples' ability to communicate openly and effectively with each other about cancer-related concerns can improve their psychological adjustment and quality of their relationship. Open and effective communication may also lead to better symptom management and goal-concordant care. However, many couples report difficulties communicating about cancer, even in the context of overall satisfying relationships. This can have a number of deleterious consequences, including deficits in emotional support, decreases in intimacy and relationship quality, and increased psychological distress. Thus, interventions designed to facilitate effective communication between cancer patients and their partners are likely to have beneficial effects on both individual and relationship functioning.

Prior research, including studies conducted by our team, has found that couple-based interventions that target communication lead to positive outcomes for cancer patients and their partners. However, most prior studies have been limited by reliance on an in-person treatment delivery format which keeps many couples from participating. In addition, prior studies have not targeted interventions to couples who are most likely to benefit. There is increasing evidence that psychosocial interventions for cancer, including couple-based interventions, should be targeted to those at risk of poor outcomes. Our prior research indicates that couples who report communication difficulties (e.g., high levels of holding back from discussing cancer-related concerns) have increased psychological distress and poorer relationship functioning and are most likely to benefit from a couple communication intervention specifically designed to addressed their communication problems.

The specific aims of this study are (1)To determine whether CCST significantly improves patients' and partners' individual psychological adjustment (i.e., psychological distress, life completion) and patient health and health care outcomes (physical well-being, symptom distress, advance care planning discussions and completion of advance directives, hospitalizations, and emergency department visits) compared to an education condition. (2) To determine whether, for couples receiving the CCST intervention, improvements in psychological adjustment, relationship functioning, and patient health are mediated by improvements in their communication, including objective measures of communication quality and communal coping (e.g., "we-talk") derived from couple conversations and self-reported protective buffering. (3) To examine differences in response to the CCST intervention for patients versus partners, for male versus female participants, and for patients with different cancer diagnoses (breast, lung, GI, GU). (4) To conduct an implementation-related process evaluation of the intervention.

研究の種類

介入

入学 (実際)

440

段階

  • 適用できない

連絡先と場所

このセクションには、調査を実施する担当者の連絡先の詳細と、この調査が実施されている場所に関する情報が記載されています。

研究場所

    • North Carolina
      • Durham、North Carolina、アメリカ、27705
        • Duke University Medical Center

参加基準

研究者は、適格基準と呼ばれる特定の説明に適合する人を探します。これらの基準のいくつかの例は、人の一般的な健康状態または以前の治療です。

適格基準

就学可能な年齢

18年歳以上 (大人、高齢者)

健康ボランティアの受け入れ

いいえ

受講資格のある性別

全て

説明

Inclusion Criteria:

  1. Married or in a committed intimate relationship
  2. Diagnosis of one the following advanced cancers: Stage IIIB or IV non-small cell lung cancer or extensive stage small cell lung cancer, Stage III pancreatic cancer or Stage IV GI cancer, Stage IV GU cancer, Stage IV breast cancer and GYN cancer Stage III-IV ovarian, IV uterine, IV cervical.
  3. Both members of the couple must speak and read English.
  4. Patient and/or partner scores >=1.0 on the Holding Back screen.

Exclusion Criteria:

  1. Patient lacks capacity for interview (documented diagnosis of active psychosis or dementia) or is unable to provide informed consent as assessed by research staff.
  2. Patient has a life expectancy < 6 months as estimated by his/her treating oncologist.
  3. Patient or partner is physically impaired in such a way that precludes the use of a computer or videoconferencing.
  4. Patient or partner is too sick to participate, as judged by the oncologist or research staff.

研究計画

このセクションでは、研究がどのように設計され、研究が何を測定しているかなど、研究計画の詳細を提供します。

研究はどのように設計されていますか?

デザインの詳細

  • 主な目的:支持療法
  • 割り当て:ランダム化
  • 介入モデル:並列代入
  • マスキング:なし(オープンラベル)

武器と介入

参加者グループ / アーム
介入・治療
他の:Couple Communication and Support

CCST includes components to assist couples in communicating effectively, decreasing avoidance of important cancer-related issues, and providing each other with support. It includes training in skills for sharing one's thoughts and feelings and listening to one's partner and responding in a supportive manner, and joint problem solving. Participants will be asked to participate inactivities at home between sessions to strengthen skills acquisition.

Participants attend six 60-minute sessions consisting of education and skills training to enhance cancer-related communication.

他の名前:
  • CCST
他の:Healthy Lifestyle Informaion

Healthy Lifestyle Information provides couples with health information relevant to cancer in a supportive environment. Sessions focus on the following topics: fatigue, sleep disturbance, nutrition, physical activity, survivorship care plans, and palliative care. Patients and partners are invited to discuss their experiences around the session topics with the therapist and ask questions about the information presented.

Participants attend attend six 60-minute sessions consisting of information and support across a range of cancer-related topics.

他の名前:
  • HLI

この研究は何を測定していますか?

主要な結果の測定

結果測定
メジャーの説明
時間枠
Changes in patient relationship functioning
時間枠:Baseline, end of intervention (up to 8 months), 3 month post intervention follow-up

Change in patient relationship satisfaction measured by the Couples Satisfaction Inventory (higher scores indicate higher satisfaction)

Baseline, end of intervention (up to 8 months), 3 month post intervention follow-up
Changes in partner relationship functioning
時間枠:Baseline, end of intervention (up to 8 months), 3 month post intervention follow-up

Change in partner relationship satisfaction measured by the Couples Satisfaction Inventory (higher scores indicate higher satisfaction)

Baseline, end of intervention (up to 8 months), 3 month post intervention follow-up
Changes in patient relationship functioning
時間枠:Baseline, end of intervention (up to 8 months), 3 month post intervention follow-up

Change in patient intimacy as measured by the Miller Social Intimacy Scale (higher scores indicate higher intimacy)

Baseline, end of intervention (up to 8 months), 3 month post intervention follow-up
Changes in partner relationship functioning
時間枠:Baseline, end of intervention (up to 8 months), 3 month post intervention follow-up

Change in partner intimacy as measured by the Miller Social Intimacy Scale (higher scores indicate higher intimacy)

Baseline, end of intervention (up to 8 months), 3 month post intervention follow-up

二次結果の測定

結果測定
メジャーの説明
時間枠
Changes in patient psychological functioning
時間枠:Baseline, end of intervention (up to 8 months), 3 month post intervention follow-up

Change in patient psychological distress measured by the Hospital Anxiety and Depression Scale (higher scores indicate higher distress)

Baseline, end of intervention (up to 8 months), 3 month post intervention follow-up
Changes in partner psychological functioning
時間枠:Baseline, end of intervention (up to 8 months), 3 month post intervention follow-up

Change in partner psychological distress measured by the Hospital Anxiety and Depression Scale (higher scores indicate higher distress)

Baseline, end of intervention (up to 8 months), 3 month post intervention follow-up
Changes in patient psychological functioning
時間枠:Baseline, end of intervention (up to 8 months), 3 month post intervention follow-up

Change in patient mood as measured by the Positive and Negative Mood Scale (higher scores on the positive and negative mood subscales indicate higher negative and positive mood, respectively)

Baseline, end of intervention (up to 8 months), 3 month post intervention follow-up
Changes in partner psychological functioning
時間枠:Baseline, end of intervention (up to 8 months), 3 month post intervention follow-up

Change in partner mood as measured by the Positive and Negative Mood Scale (higher scores on the positive and negative mood subscales indicate higher negative and positive mood, respectively)

Baseline, end of intervention (up to 8 months), 3 month post intervention follow-up
Changes in patient psychological functioning
時間枠:Baseline, end of intervention (up to 8 months), 3 month post intervention follow-up

Change in patient life completion measured by the Life Completion scale of the QUAL-E (higher scores indicate higher completion)

Baseline, end of intervention (up to 8 months), 3 month post intervention follow-up
Changes in partner psychological functioning
時間枠:Baseline, end of intervention (up to 8 months), 3 month post intervention follow-up

Change in partner life completion measured by the Life Completion scale of the QUAL-E Family (higher scores indicate higher completion)

Baseline, end of intervention (up to 8 months), 3 month post intervention follow-up
Changes in patient psychological functioning
時間枠:Baseline, end of intervention (up to 8 months), 3 month post intervention follow-up

Change in patient physical well being as measured by the Physical Well Being subscale of the Functional Assessment of Cancer Therapy scale (higher scores indicate higher physical well being)

Baseline, end of intervention (up to 8 months), 3 month post intervention follow-up
Changes in patient and partner psychological functioning
時間枠:Baseline, end of intervention (up to 8 months), 3 month post intervention follow-up

Change in symptom distress as measured by the Condensed Memorial Symptom Assessment Scale (higher scores indicate higher symptom distress)

Baseline, end of intervention (up to 8 months), 3 month post intervention follow-up
Changes in patient psychological functioning
時間枠:Baseline, end of intervention (up to 8 months), 3 month post intervention follow-up

Change in patient advance care planning discussions (presence or absence, via patient self-report)

Baseline, end of intervention (up to 8 months), 3 month post intervention follow-up
Changes in patient psychological functioning
時間枠:Baseline, end of intervention (up to 8 months), 3 month post intervention follow-up

Change in patient completion of advanced directives (presence or absence, via patient self-report)

Baseline, end of intervention (up to 8 months), 3 month post intervention follow-up
Changes in patient psychological functioning
時間枠:Baseline, end of intervention (up to 8 months), 3 month post intervention follow-up

Change in patient hospitalizations (number of hospitalizations per patient self-report, validated by medical record review)

Baseline, end of intervention (up to 8 months), 3 month post intervention follow-up
Changes in patient psychological functioning
時間枠:Baseline, end of intervention (up to 8 months), 3 month post intervention follow-up

Change in patient emergency department visits (number of emergency department visits per patient self-report, validated by medical record review)

Baseline, end of intervention (up to 8 months), 3 month post intervention follow-up

協力者と研究者

ここでは、この調査に関係する人々や組織を見つけることができます。

スポンサー

捜査官

  • 主任研究者:Laura Porter, PhD、Duke

出版物と役立つリンク

研究に関する情報を入力する責任者は、自発的にこれらの出版物を提供します。これらは、研究に関連するあらゆるものに関するものである可能性があります。

研究記録日

これらの日付は、ClinicalTrials.gov への研究記録と要約結果の提出の進捗状況を追跡します。研究記録と報告された結果は、国立医学図書館 (NLM) によって審査され、公開 Web サイトに掲載される前に、特定の品質管理基準を満たしていることが確認されます。

主要日程の研究

研究開始 (実際)

2020年10月20日

一次修了 (実際)

2025年12月31日

研究の完了 (実際)

2025年12月31日

試験登録日

最初に提出

2020年10月9日

QC基準を満たした最初の提出物

2020年10月15日

最初の投稿 (実際)

2020年10月19日

学習記録の更新

投稿された最後の更新 (実際)

2026年11月17日

QC基準を満たした最後の更新が送信されました

2026年11月13日

最終確認日

2026年11月1日

詳しくは

本研究に関する用語

その他の研究ID番号

  • Pro00103232

個々の参加者データ (IPD) の計画

個々の参加者データ (IPD) を共有する予定はありますか?

いいえ

医薬品およびデバイス情報、研究文書

米国FDA規制医薬品の研究

いいえ

米国FDA規制機器製品の研究

いいえ

この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。

購読する